Efficacy of Etanercept in Psoriatic Patients Previously Treated with Infliximab

Publisher： Karger

E-ISSN： 1421-9832|216|4|312-316

ISSN： 1018-8665

Source： Dermatology, Vol.216, Iss.4, 2008-01, pp. : 312-316

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of Efalizumab in Psoriasis Patients Previously Treated with Tumour Necrosis Factor Blockers

By  

Dermatology, Vol. 219, Iss. 1, 2009-04 ,pp. : 48-53

Karger

Access to resources Recommend Favorite

Golimumab in Patients Affected by Moderate to Severe Psoriatic Arthritis: An Open-Label Study in Thirty-Two Patients Previously Treated with Other Biologics

By  

Dermatology, Vol. 227, Iss. 4, 2013-11 ,pp. : 305-310

Karger

Access to resources Recommend Favorite

Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study

By  

Dermatology, Vol. 225, Iss. 4, 2012-12 ,pp. : 312-319

Karger

Access to resources Recommend Favorite

Prevalence and Management of Panic Attacks during Infliximab Infusion in Psoriatic Patients

By  

Dermatology, Vol. 225, Iss. 3, 2012-11 ,pp. : 236-241

Karger

Access to resources Recommend Favorite

Th1, Th2, Th17 and Regulatory T Cell Pattern in Psoriatic Patients: Modulation of Cytokines and Gene Targets Induced by Etanercept Treatment and Correlation with Clinical Response

By  

Dermatology, Vol. 223, Iss. 1, 2011-08 ,pp. : 57-67

Karger

Access to resources Recommend Favorite